Metallophores Drive Staphylococcus aureus Virulence and Pathogenicity Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

July 8, 2025

  • Metals
    Metals

    OverviewHeavy metals play a significant and multifaceted role in the pathogenicity of microbial species. Their involvement can be viewed from two primary perspectives: the toxicity of heavy metals to microbes and the exploitation of heavy metals by microbial pathogens to establish infections and evade the host immune response. Understanding these aspects is critical for both […]

  • Microbes
    Microbes

    Microbes, short for microorganisms, are tiny living organisms that are ubiquitous in the environment, including on and inside the human body. They play a crucial role in human health and disease, functioning within complex ecosystems in various parts of the body, such as the skin, mouth, gut, and respiratory tract. The human microbiome, which is […]

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Last Updated: 2025

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was reviewed?

This review article comprehensively examined the role of metallophores in the pathogenicity and virulence of Staphylococcus aureus, emphasizing their molecular structures, biosynthetic pathways, transport mechanisms, and regulatory systems. The authors detail the distinct types of metallophores produced by S. aureus—including staphyloferrin A, staphyloferrin B, staphylobactin, aureochelin, and the broad-spectrum staphylopine—highlighting their importance in overcoming host nutritional immunity during infection.

Who was reviewed?

The review synthesizes data from numerous studies involving both in vitro and in vivo models, including murine infection systems. It primarily focuses on Staphylococcus aureus as a pathogen, but also references bacterial competitors and host immune responses to illustrate how metallophores enable S. aureus to outcompete other microbes and evade host defenses.

Most important findings

Metallophores are crucial for S. aureus to acquire essential metal ions under host-imposed metal-limiting conditions. The review identifies two primary iron-chelating siderophores (staphyloferrin A and B), a hydroxamate-type siderophore (staphylobactin), and the less-characterized aureochelin. Staphylopine, a nicotianamine-like opine metallophore, is distinguished by its ability to chelate multiple metals, including zinc and nickel. The regulation of metallophore systems is tightly controlled by metal-responsive regulators Fur and Zur. Notably, staphylopine acts as a zincophore, essential in zinc-limited environments. S. aureus also imports xenosiderophores produced by other microbes, further enhancing its adaptability and virulence.

Table: Summary of S. aureus Metallophores

MetallophoreMetal Target(s)Regulatory ProteinsTransporter
Staphyloferrin AIronFurHtsABC
Staphyloferrin BIronFurSirABC
StaphylobactinIronFurSirABC
AureochelinIron (phenolate/catecholate)UnknownUnknown
StaphylopineZn, Ni, Co, Cu, Fe (broad)Fur and ZurCntABCDF, CntE export

Key implications

Understanding the metallophore-mediated metal acquisition systems of S. aureus reveals critical virulence mechanisms that could be therapeutically targeted. Disrupting these systems—especially the staphylopine pathway—could impair bacterial fitness under nutrient-limited conditions, attenuate virulence, and enhance susceptibility to host immune defenses. The insights into regulatory systems (Fur/Zur) and unique transporters also pave the way for antimicrobial strategies that block metallophore synthesis or function without relying on traditional antibiotics.

Zinc

Zinc is an essential trace element vital for cellular functions and microbiome health. It influences immune regulation, pathogen virulence, and disease progression in conditions like IBS and breast cancer. Pathogens exploit zinc for survival, while therapeutic zinc chelation can suppress virulence, rebalance the microbiome, and offer potential treatments for inflammatory and degenerative diseases.

Nickel

Bacteria regulate transition metal levels through complex mechanisms to ensure survival and adaptability, influencing both their physiology and the development of antimicrobial strategies.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.